New numbing shot may slash post-surgery pain for lung cancer patients

NCT ID NCT07134660

Recruiting now Symptom relief Sponsor: Shanghai Pulmonary Hospital, Shanghai, China Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 01, 2026 · Updated 27 times

Summary

This study compares a long-acting numbing medicine (liposomal bupivacaine) to a standard one for pain control after lung surgery. About 210 adults having keyhole lung surgery will be randomly assigned to receive one of the two drugs or no nerve block. The goal is to see if the long-acting version provides better pain relief from 25 to 72 hours after surgery, which could help patients recover faster and use fewer opioids.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Shanghai pulmonary hospital
RECRUITING

Shanghai, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

LUNG CANCER POSTOPERATIVE PAIN, ACUTE POSTOPERATIVE PAIN, ACUTE